| UniProt ID | NCLN_HUMAN | |
|---|---|---|
| UniProt AC | Q969V3 | |
| Protein Name | Nicalin | |
| Gene Name | NCLN | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 563 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein . |
|
| Protein Description | May antagonize Nodal signaling and subsequent organization of axial structures during mesodermal patterning.. | |
| Protein Sequence | MLEEAGEVLENMLKASCLPLGFIVFLPAVLLLVAPPLPAADAAHEFTVYRMQQYDLQGQPYGTRNAVLNTEARTMAAEVLSRRCVLMRLLDFSYEQYQKALRQSAGAVVIILPRAMAAVPQDVVRQFMEIEPEMLAMETAVPVYFAVEDEALLSIYKQTQAASASQGSASAAEVLLRTATANGFQMVTSGVQSKAVSDWLIASVEGRLTGLGGEDLPTIVIVAHYDAFGVAPWLSLGADSNGSGVSVLLELARLFSRLYTYKRTHAAYNLLFFASGGGKFNYQGTKRWLEDNLDHTDSSLLQDNVAFVLCLDTVGRGSSLHLHVSKPPREGTLQHAFLRELETVAAHQFPEVRFSMVHKRINLAEDVLAWEHERFAIRRLPAFTLSHLESHRDGQRSSIMDVRSRVDSKTLTRNTRIIAEALTRVIYNLTEKGTPPDMPVFTEQMQIQQEQLDSVMDWLTNQPRAAQLVDKDSTFLSTLEHHLSRYLKDVKQHHVKADKRDPEFVFYDQLKQVMNAYRVKPAVFDLLLAVGIAAYLGMAYVAVQHFSLLYKTVQRLLVKAKTQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 75 | Sulfoxidation | LNTEARTMAAEVLSR HCHHHHHHHHHHHHH | 2.50 | 21406390 | |
| 94 | Phosphorylation | MRLLDFSYEQYQKAL HHHHCCCHHHHHHHH | 13.67 | 28152594 | |
| 97 | Phosphorylation | LDFSYEQYQKALRQS HCCCHHHHHHHHHHH | 10.47 | 28152594 | |
| 99 (in isoform 1) | Ubiquitination | - | 44.44 | 21890473 | |
| 99 (in isoform 2) | Ubiquitination | - | 44.44 | 21890473 | |
| 99 | Ubiquitination | FSYEQYQKALRQSAG CCHHHHHHHHHHHCC | 44.44 | 27667366 | |
| 116 | Sulfoxidation | VIILPRAMAAVPQDV EEECCHHHHCCCHHH | 2.31 | 21406390 | |
| 178 | Phosphorylation | AAEVLLRTATANGFQ HHHHHHHHHHHCCEE | 28.47 | - | |
| 193 | Phosphorylation | MVTSGVQSKAVSDWL EECCCCCCHHHCCHH | 21.85 | 20068231 | |
| 194 (in isoform 1) | Ubiquitination | - | 35.40 | 21890473 | |
| 194 | Ubiquitination | VTSGVQSKAVSDWLI ECCCCCCHHHCCHHH | 35.40 | 21906983 | |
| 194 (in isoform 2) | Ubiquitination | - | 35.40 | 21890473 | |
| 241 | N-linked_Glycosylation | LSLGADSNGSGVSVL HHCCCCCCCCHHHHH | 49.55 | UniProtKB CARBOHYD | |
| 262 | Ubiquitination | FSRLYTYKRTHAAYN HHHHHHHCHHHHHHH | 42.91 | - | |
| 275 | Phosphorylation | YNLLFFASGGGKFNY HHEEEEECCCCCCCC | 32.58 | - | |
| 286 | Ubiquitination | KFNYQGTKRWLEDNL CCCCCCHHHHHHHCC | 48.69 | 21906983 | |
| 286 (in isoform 1) | Ubiquitination | - | 48.69 | 21890473 | |
| 286 (in isoform 2) | Ubiquitination | - | 48.69 | 21890473 | |
| 286 | 2-Hydroxyisobutyrylation | KFNYQGTKRWLEDNL CCCCCCHHHHHHHCC | 48.69 | - | |
| 318 | Phosphorylation | LDTVGRGSSLHLHVS EECCCCCCCEEEEEC | 28.50 | 27080861 | |
| 319 | Phosphorylation | DTVGRGSSLHLHVSK ECCCCCCCEEEEECC | 23.72 | 27080861 | |
| 326 (in isoform 2) | Ubiquitination | - | 58.93 | 21890473 | |
| 326 (in isoform 1) | Ubiquitination | - | 58.93 | 21890473 | |
| 326 | Ubiquitination | SLHLHVSKPPREGTL CEEEEECCCCCCCCH | 58.93 | 22817900 | |
| 359 | Ubiquitination | VRFSMVHKRINLAED CCHHHHHHCCCHHHH | 43.49 | - | |
| 359 | 2-Hydroxyisobutyrylation | VRFSMVHKRINLAED CCHHHHHHCCCHHHH | 43.49 | - | |
| 397 | Phosphorylation | SHRDGQRSSIMDVRS HCCCCCCCCHHHHHH | 19.14 | - | |
| 398 | Phosphorylation | HRDGQRSSIMDVRSR CCCCCCCCHHHHHHH | 24.91 | - | |
| 409 | Ubiquitination | VRSRVDSKTLTRNTR HHHHCCCCCCCCHHH | 42.99 | 27667366 | |
| 409 (in isoform 2) | Ubiquitination | - | 42.99 | - | |
| 423 | Phosphorylation | RIIAEALTRVIYNLT HHHHHHHHHHHHHHH | 29.91 | 20068231 | |
| 428 | N-linked_Glycosylation | ALTRVIYNLTEKGTP HHHHHHHHHHCCCCC | 29.39 | UniProtKB CARBOHYD | |
| 434 | Phosphorylation | YNLTEKGTPPDMPVF HHHHCCCCCCCCCCC | 42.59 | 20068231 | |
| 442 | Phosphorylation | PPDMPVFTEQMQIQQ CCCCCCCCHHHHHHH | 26.07 | 20068231 | |
| 460 | Phosphorylation | DSVMDWLTNQPRAAQ HHHHHHHHCCHHHHH | 27.79 | 20068231 | |
| 470 (in isoform 2) | Ubiquitination | - | 58.60 | 21890473 | |
| 470 | Ubiquitination | PRAAQLVDKDSTFLS HHHHHHCCCCCHHHH | 58.60 | 21963094 | |
| 471 | Acetylation | RAAQLVDKDSTFLST HHHHHCCCCCHHHHH | 46.21 | 26051181 | |
| 471 (in isoform 1) | Ubiquitination | - | 46.21 | 21890473 | |
| 471 | Ubiquitination | RAAQLVDKDSTFLST HHHHHCCCCCHHHHH | 46.21 | 21906983 | |
| 487 | Ubiquitination | EHHLSRYLKDVKQHH HHHHHHHHHHHHHHH | 3.57 | 27667366 | |
| 488 | Ubiquitination | HHLSRYLKDVKQHHV HHHHHHHHHHHHHHC | 52.09 | 27667366 | |
| 490 | Ubiquitination | LSRYLKDVKQHHVKA HHHHHHHHHHHHCCC | 6.50 | 29967540 | |
| 491 | Ubiquitination | SRYLKDVKQHHVKAD HHHHHHHHHHHCCCC | 54.79 | 29967540 | |
| 491 | 2-Hydroxyisobutyrylation | SRYLKDVKQHHVKAD HHHHHHHHHHHCCCC | 54.79 | - | |
| 495 | Ubiquitination | KDVKQHHVKADKRDP HHHHHHHCCCCCCCC | 5.26 | 22817900 | |
| 496 | Ubiquitination | DVKQHHVKADKRDPE HHHHHHCCCCCCCCC | 46.65 | 22817900 | |
| 498 (in isoform 2) | Ubiquitination | - | 40.58 | 21890473 | |
| 498 | Ubiquitination | KQHHVKADKRDPEFV HHHHCCCCCCCCCCC | 40.58 | 22817900 | |
| 499 (in isoform 1) | Ubiquitination | - | 64.66 | 21890473 | |
| 499 | Ubiquitination | QHHVKADKRDPEFVF HHHCCCCCCCCCCCH | 64.66 | 21906983 | |
| 510 (in isoform 2) | Ubiquitination | - | 3.70 | 21890473 | |
| 510 | Ubiquitination | EFVFYDQLKQVMNAY CCCHHHHHHHHHHHH | 3.70 | 22817900 | |
| 511 (in isoform 1) | Ubiquitination | - | 34.90 | 21890473 | |
| 511 | Ubiquitination | FVFYDQLKQVMNAYR CCHHHHHHHHHHHHC | 34.90 | 22817900 | |
| 558 | Ubiquitination | KTVQRLLVKAKTQ-- HHHHHHHHHHHCC-- | 7.20 | 27667366 | |
| 559 | Ubiquitination | TVQRLLVKAKTQ--- HHHHHHHHHHCC--- | 44.10 | 27667366 | |
| 560 | Ubiquitination | VQRLLVKAKTQ---- HHHHHHHHHCC---- | 16.79 | 24816145 | |
| 561 | Ubiquitination | QRLLVKAKTQ----- HHHHHHHHCC----- | 41.56 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NCLN_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NCLN_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NCLN_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NOMO1_HUMAN | NOMO1 | physical | 15257293 | |
| RPN2_HUMAN | RPN2 | physical | 26344197 | |
| SERC1_HUMAN | SERINC1 | physical | 27173435 | |
| METL9_HUMAN | METTL9 | physical | 27173435 | |
| NOMO1_HUMAN | NOMO1 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...